A Study of Financial Burden of Medical Therapy in Patients with Pulmonary Arterial Hypertension (PAH)

Overview

About this study

The purpose of this study is to:

To assess out of pocket expenditures of patients on medical therapy for Group 1 PAH, its impact on medication affordability and whether that adversely affected treatment regimens.
To analyze potential effects associated with the financial burden of PAH medical therapy.
The secondary outcome is to assess the impact of pulmonary arterial hypertension on healthy lifestyle of the patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients (age >18 years) with Pulmonary Arterial Hypertension following up at the Pulmonary Hypertension Clinic at Mayo Clinic in Florida

Exclusion Criteria:

Does not meet inclusion criteria
Non Group 1 PH Patients
Patients deceased at time of telephonic contact

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Charles Burger, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Charles Burger, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials